| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 54.21M | 54.07M | 53.19M | 58.57M | 61.16M | 61.60M |
| Gross Profit | 24.15M | 24.15M | 22.83M | 24.05M | 25.75M | 24.48M |
| EBITDA | 5.02M | 5.24M | -1.21M | 2.69M | 5.34M | 6.94M |
| Net Income | 2.32M | 2.45M | -3.53M | 514.00K | 3.11M | 4.33M |
Balance Sheet | ||||||
| Total Assets | 39.67M | 38.14M | 36.14M | 45.54M | 47.85M | 33.55M |
| Cash, Cash Equivalents and Short-Term Investments | 3.35M | 3.66M | 3.14M | 1.65M | 840.00K | 6.56M |
| Total Debt | 2.94M | 3.25M | 3.92M | 7.28M | 8.22M | 3.96M |
| Total Liabilities | 14.72M | 13.91M | 14.09M | 20.06M | 22.17M | 13.46M |
| Stockholders Equity | 24.95M | 24.22M | 22.05M | 25.48M | 25.68M | 20.09M |
Cash Flow | ||||||
| Free Cash Flow | 2.43M | 2.23M | 5.42M | 4.67M | -508.00K | 4.17M |
| Operating Cash Flow | 2.94M | 2.91M | 6.03M | 5.81M | 1.22M | 5.41M |
| Investing Cash Flow | -802.00K | -662.00K | -608.00K | -2.64M | -8.09M | -1.07M |
| Financing Cash Flow | -1.02M | -1.73M | -3.95M | -2.35M | 1.16M | -1.46M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £169.65M | 15.51 | 25.14% | 5.97% | 6.38% | -10.55% | |
72 Outperform | £17.82M | 4.66 | 9.67% | 3.17% | 2.83% | ― | |
66 Neutral | £235.54M | 3.91 | 30.98% | 2.12% | -0.89% | 1.30% | |
65 Neutral | £84.44M | -8.91 | -0.12% | ― | ― | ― | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
54 Neutral | £313.78M | 14.34 | -2.16% | 4.82% | -2.67% | 89.86% | |
42 Neutral | £27.83M | -0.15 | 97.34% | ― | -31.02% | -4458.82% |
Creightons plc reported its latest six‑monthly block admission return for its employee share option scheme, confirming that no new shares were issued or allotted under the scheme between 12 September 2025 and 12 March 2026. As a result, the balance of unallotted securities under the block admission remains unchanged at 5,138,520 ordinary shares, signalling stability in the company’s capital structure and no recent dilution for existing shareholders.
The company noted that the block admission has not been increased since the previous return, with the original 7,562,000 ordinary shares having been admitted in October 2021. This update, a routine disclosure under AIM rules, provides transparency for investors on potential future share issuance tied to employee options while indicating that staff have not exercised options in the latest reporting period.
The most recent analyst rating on (GB:CRL) stock is a Hold with a £28.00 price target. To see the full list of analyst forecasts on Creightons stock, see the GB:CRL Stock Forecast page.
Creightons plc has disclosed that non-executive director Paul Watts purchased 53,000 ordinary shares in the company at £0.278 per share on 4 February 2026, increasing his total holding to 160,000 shares. The director dealing, conducted on AIM in accordance with UK Market Abuse Regulation, signals added board-level confidence in the business and provides investors with updated information on insider share ownership.
The most recent analyst rating on (GB:CRL) stock is a Buy with a £30.00 price target. To see the full list of analyst forecasts on Creightons stock, see the GB:CRL Stock Forecast page.
Creightons plc has disclosed that Steve Denison, a person closely associated with non-executive director Jemima Bird, purchased 52,994 ordinary shares in the company at a price of £0.2677 per share. The share acquisition, carried out on 28 January 2026 on AIM, represents a notified insider dealing under UK Market Abuse Regulation, signalling increased aligned interest from a party connected to the company’s board but without any stated change to corporate strategy or operations.
The most recent analyst rating on (GB:CRL) stock is a Buy with a £29.00 price target. To see the full list of analyst forecasts on Creightons stock, see the GB:CRL Stock Forecast page.